` 학술지 열람 - 학술지(BCJ) : (사)한국바이오칩학회 (The Korean BioChip Society)
Go to contents

(사)한국바이오칩학회 The Korean BioChip Society





BT+IT+NT융합시대의 리더 : 한국바이오칩학회

학술지 열람

논문 정보 자세히 보기

Info. Vol.5 - No.1 (2011.03.20)
Title Protein profiling predicts the response to anthracycline and taxanes based neo-adjuvant chemotherapy in breast cancer
Authors Shu Wang1, Houpu Yang1, Jiajia Guo1, Miao Liu1, Fuzhong Tong1, Yingming Cao1, Bo Zhou1, Peng Liu1, Hongjun Liu1, Lin Cheng1, Fei Xie1, Deqi Yang1 & Jiaqing Zhang1
Institutions 1Breast Disease Center, Peking University, People?셲 Hospital, Beijing 100044, China
Correspondence and requests for materials should be addressed to S. Wang ( wangshu@pkuph.edu.cn)
Abstract Neo-adjuvant chemotherapy for breast cancer substantially benefits patients who achieve pathological response. However, clinical or pathological response information can only be obtained a period of time after chemotherapy. The identification of novel bio-markers or the application of new technique that can be used to predict treatment response before chemotherapy would allow therapy to be tailored on an individual patient basis. The purpose of this study is to identify the chemo-sensitivity and chemo-resistance related proteins using antibody microarray profiling, and to develop a multi-protein predictive model for breast cancer. Total protein was extracted from core needle biopsy samples obtained from 15 patients before treatment with neo-adjuvant TA(combination of taxanes and anthracycline) chemotherapy. Protein profiling was analyzed by antibody microarray. 10 patients were used as training set to develop the predictive model using the software PAM(prediction analysis of microarray). Another 5 patients were used as a validation set to test the model. In cross-validation, the molecular predictive model showed an accuracy of 90%, in independent validation, the model classified the cases with an accuracy of 80%. In conclusion, the proteomic predictive model has the potential to predict pathological response to neo-adjuvant TA chemotherapy.
Keyword Breast cancer, Proteomic profiling, Antibody microarray, Neo-adjuvant hemotherapy, Predictive model
PDF File
# 2010년도 발행분 부터는 Springer 의 BioChip Journal 페이지에서 전문을 열람하실 수 있습니다.
# 학회회원 로그인 후 [ Springer BioChip Journal 열람하기 ] 버튼을 클릭하시면 새창으로 열립니다.
→ 전체 목록 보기

(사)한국바이오칩학회 (The Korean BioChip Society)
총괄/후원/부스/저널/학술대회
전화 : 070-7767-9855
전자우편 : biochip@biochip.or.kr
등록/초록/학술대회/e-컨퍼런스/
회원정보/홈페이지
전화 : 070-7767-9867
전자우편 : biochip2@biochip.or.kr
주소 : (우)06130, 서울특별시 강남구 테헤란로7길 22 과학기술회관 1관 804호    대표자 : 박현규   고유번호 : 206-82-65403   팩스 : 02-921-9856
웹사이트 : https://www.biochips.or.kr Copyright © The Korean BioChip Society. All Rights Reserved.